We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » HighQ partners with SAFE-BioPharma

HighQ partners with SAFE-BioPharma

December 7, 2011
CenterWatch Staff

London-based HighQ has formed a vendor partnership with the SAFE-BioPharma Association. Companies within the global pharmaceutical and biotechnology industry use the SAFE-BioPharma standard in FDA Title 21 CFR part 11 compliant processes for signing SOPs, quality and compliance documentation, research and development documentation, corporate compliance documents and more.

HighQ provides the life sciences industry with a unified space for secure document exchange and social collaboration across a global network of employees, researchers and partners – both internal and external to the company. HighQ Collaborate, a secure cloud-based platform, allows users to disseminate information to discovery teams, CROs, investigators and business development partners worldwide. Users will have the opportunity to securely exchange documents using their SAFE-BioPharma digital identities on the HighQ Collaborate platform, ensuring their credentials are available anytime and anywhere.

"By making use of collaborative tools such as wiki pages and blog posts alongside traditional office software (Word, Excel, PowerPoint, PDF etc.), sponsors, CROs and investigators can work more efficiently, eliminating the time consuming need to print out physical documents that require signatures during clinical trials. By partnering with the SAFE-BioPharma Association, HighQ will enable the life sciences industry to have an efficient, enforceable and regulatory-compliant document approval process, whilst facilitating secure document exchange and social collaboration throughout the organization," said Jacob Mathew, consultant – KM Practice, HighQ.

Global News Technology Solutions
  • Related Directories

    Complion

    IRBNet

    CROMSOURCE

Upcoming Events

  • 09Dec

    The Age of eSource: Modernizing Clinical Trials

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Patient-phsyician-consultation

    Giving Patients Back Their Voice in Clinical Trials

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing